Skip to main content
Caplight Logo









Interface Biosciences

Interface Biosciences

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://interface.bio/

Last Round

Seed

Dec 5, 2023

Total Funding Raised

$3M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Interface Biosciences is a biotechnology company that operates an AI-enabled, metabolomics-based drug discovery platform to develop therapies for inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

AI drug discoverydrug discovery platformimmunotherapymicrobiome therapeuticsAI biotechpreclinical biotechcomputational biologymolecular engineeringpeptide engineeringimmuno-oncologyinflammatory disease therapeuticstherapeutic peptidesnatural product discoverytargeted metabolomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Interface Biosciences Comparables

Compare Interface Biosciences with similar companies based on industry and business-model similarity.

Interface Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Enterome
78%
Kanvas Biosciences
76%
Siolta Therapeutics
74%

Interface Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 5, 2023

Key People

Founding team and executive leadership

Will Van Treuren

Chief Scientific Officer and Co-Founder

Founding Team

Interface Biosciences Investors

Notable investors and investment history

Interface Biosciences investors
InvestorRounds
Pacific 8 VenturesSeed
GaingelsSeed
Boom CapitalSeed
Pear VCSeed
LongeVCSeed
Ulu VenturesSeed
SeedFolioSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 507% MoM, reaching 2.5K.

  • Jul 20, 2026

    Open roles increased from 0 to 2, representing 100% of headcount.

Interface Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Interface Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Interface Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range2
Year Founded2020
Last FundingDec 5, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?